NCT05939908

Brief Summary

Hand grip strength will be measured for all the type 2 diabetic patients. Measurement of maximal grip strength will be performed using Jamar dynamometers, which estimate the muscle strength primarily generated by the flexor muscles of the hand and the forearm. The Jamar displays grip force in both pounds and kilograms, with a maximum of 200 lb (90 kg). It has a peak-hold needle that automatically retains the highest reading until reset. The Jamar test is isometric, with no perceptible motion of the handle, regardless of the grip strength applied. The participants will be encouraged to produce their maximal grip strength. Three trials will be recorded, consisting of a 2-4-second maximal contraction, with a 30-second rest period between each trial. The average of the three readings will be taken.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 3, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 11, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2025

Completed
Last Updated

July 11, 2023

Status Verified

July 1, 2023

Enrollment Period

1.5 years

First QC Date

July 3, 2023

Last Update Submit

July 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparison of age and gender specific prevalence of sarcopenia using HGS in patients with T2DM

    6 days

Interventions

Hand grip strength as a marker by using JAMAR hand grip dynamometer in patients with T2DM.

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

T2DM patient visiting Fortis CDOC Hospital and meeting the Inclusion Criteria will be enrolled in the study.

You may qualify if:

  • All patients with Type 2 diabetes of any duration coming for first time in OPD

You may not qualify if:

  • Patients with hand fracture
  • Thyroid dysfunction
  • Any musculoskeletal condition causing difficulty in holding the dynamometer
  • Patients with type1 diabetes (T1DM) and gestational diabetes (GDM)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fortis CDOC Hospital

Delhi, 110048, India

RECRUITING

MeSH Terms

Interventions

Hand Strength

Intervention Hierarchy (Ancestors)

Muscle StrengthPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Anoop Misra, MD

    Fortis CDOC Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anoop Misra, MD

CONTACT

Bhavya Arora, M.Sc

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

July 3, 2023

First Posted

July 11, 2023

Study Start

July 1, 2023

Primary Completion

December 31, 2024

Study Completion

January 30, 2025

Last Updated

July 11, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations